This topic contains a solution. Click here to go to the answer

Author Question: The nurse is preparing a presentation on chronic pain management to a group of elderly members of a ... (Read 43 times)

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
The nurse is preparing a presentation on chronic pain management to a group of elderly members of a community senior citizens center. Which chronic disease should the nurse focus on in her presentation?
 
  A) Rheumatoid arthritis
  B) Amputation
  C) Neuropathy
  D) Osteoarthritis

Question 2

The nurse performs an assessment on a newly admitted elderly patient. The patient receives a score of 12 on the Braden scale. What is the risk for impaired skin integrity for this patient?
 
  A) No risk
  B) Low risk
  C) Moderate risk
  D) High risk



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

essyface1

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

Ans: D

Answer to Question 2

Ans: D



daltonest1984

  • Hero Member
  • *****
  • Posts: 536
Both answers were spot on, thank you once again




 

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library